Disappearance of a virilizing adrenal tumor following therapy with cyproterone acetate.

Abstract

A 57-year-old woman presented with an apparently obvious diagnosis of iatrogenic virilization. At the age of 51, she began a 4-year treatment with prednisone or cyclosporine, which are known to promote hair growth, for Behçet disease. At the age of 56, osteoporosis was overtreated with the anabolic steroid nandrolone. Insignificant inhibition by dexamethasone of the extremely high serum concentrations of testosterone and less high concentrations of weak androgens prompted us to search for a virilizing tumor. Computed tomography showed a 2.3 x 1.5 cm nodule in the right adrenal gland. As the patient refused surgery, virilization was treated with the antiandrogen cyproterone acetate (CPA), but for only 4 months because clinical and hormone abnormalities reversed and the tumor was no longer visible. The patient remains symptom-free. This first report of a curative effect of CPA on a purely virilizing adrenal tumor opens new avenues in the management of such tumors.

• Authors: A Lasco, E Morini, D Maglitto, A Campennì, S Benvenga
• Journal: Endocrine-related cancer (Endocr Relat Cancer) Vol. 12 Issue 4 Pg. 939-44 (Dec 2005) ISSN: 1351-0088 [Print] England
• PMID: 16322333 (Publication Type: Case Reports, Journal Article)

Chemical References

• Androgen Antagonists
• Antineoplastic Agents
• Cyproterone Acetate

Topics

• Adrenal Gland Neoplasms (complications, diagnostic imaging, drug therapy)
• Androgen Antagonists (therapeutic use)
• Antineoplastic Agents (therapeutic use)
• Cyproterone Acetate (therapeutic use)
• Female
• Humans
• Iatrogenic Disease
• Middle Aged
• Tomography, X-Ray Computed
• Treatment Outcome
• Virilism (diagnosis, drug therapy, etiology)